The global Structural Heart Occlusion Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Structural heart occlusion devices are specialized medical tools designed to treat various structural heart diseases by closing abnormal openings or defects in the heart. These devices enable minimally invasive procedures, which offer significant benefits over traditional open-heart surgeries.

From a downstream perspective, Congenital Heart Disease accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Structural Heart Occlusion Devices leading manufacturers including Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, LifeTech, Lepu Scientech Medical, Beijing Balance Medical, Bluesail Medical, Shanghai HeartCare Medical, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Structural Heart Occlusion Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Structural Heart Occlusion Devices Market Report

Report Metric	Details
Report Name	Structural Heart Occlusion Devices Market
Segment by Type	Patent Ductus Arteriosis (PDA) Occluder Atrial Septal Defects (ASD) Occluder Ventricular Septal Defects (VSD) Occluder Left Atrial Appendage （LAA） Occluder Patent Foramen Ovale (PFO) Occluder
Segment by Application	Congenital Heart Disease Cardioembolic Stroke
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, LifeTech, Lepu Scientech Medical, Beijing Balance Medical, Bluesail Medical, Shanghai HeartCare Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Structural Heart Occlusion Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Structural Heart Occlusion Devices Market report?

Ans: The main players in the Structural Heart Occlusion Devices Market are Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, LifeTech, Lepu Scientech Medical, Beijing Balance Medical, Bluesail Medical, Shanghai HeartCare Medical

What are the Application segmentation covered in the Structural Heart Occlusion Devices Market report?

Ans: The Applications covered in the Structural Heart Occlusion Devices Market report are Congenital Heart Disease, Cardioembolic Stroke

What are the Type segmentation covered in the Structural Heart Occlusion Devices Market report?

Ans: The Types covered in the Structural Heart Occlusion Devices Market report are Patent Ductus Arteriosis (PDA) Occluder, Atrial Septal Defects (ASD) Occluder, Ventricular Septal Defects (VSD) Occluder, Left Atrial Appendage （LAA） Occluder, Patent Foramen Ovale (PFO) Occluder

1 Study Coverage

1.1 Introduction to Structural Heart Occlusion Devices: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Structural Heart Occlusion Devices Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Patent Ductus Arteriosis (PDA) Occluder

1.2.3 Atrial Septal Defects (ASD) Occluder

1.2.4 Ventricular Septal Defects (VSD) Occluder

1.2.5 Left Atrial Appendage （LAA） Occluder

1.2.6 Patent Foramen Ovale (PFO) Occluder

1.3 Market Segmentation by Application

1.3.1 Global Structural Heart Occlusion Devices Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Congenital Heart Disease

1.3.3 Cardioembolic Stroke

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Structural Heart Occlusion Devices Revenue Estimates and Forecasts 2020-2031

2.2 Global Structural Heart Occlusion Devices Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Structural Heart Occlusion Devices Sales Estimates and Forecasts 2020-2031

2.4 Global Structural Heart Occlusion Devices Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Structural Heart Occlusion Devices Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Structural Heart Occlusion Devices Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Patent Ductus Arteriosis (PDA) Occluder Market Size by Manufacturers

3.5.2 Atrial Septal Defects (ASD) Occluder Market Size by Manufacturers

3.5.3 Ventricular Septal Defects (VSD) Occluder Market Size by Manufacturers

3.5.4 Left Atrial Appendage （LAA） Occluder Market Size by Manufacturers

3.5.5 Patent Foramen Ovale (PFO) Occluder Market Size by Manufacturers

3.6 Global Structural Heart Occlusion Devices Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Structural Heart Occlusion Devices Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Structural Heart Occlusion Devices Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Structural Heart Occlusion Devices Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Structural Heart Occlusion Devices Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Structural Heart Occlusion Devices Sales and Revenue by Type (2020-2031)

6.4 North America Structural Heart Occlusion Devices Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Structural Heart Occlusion Devices Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Structural Heart Occlusion Devices Sales and Revenue by Type (2020-2031)

7.4 Europe Structural Heart Occlusion Devices Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Structural Heart Occlusion Devices Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Structural Heart Occlusion Devices Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Structural Heart Occlusion Devices Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Structural Heart Occlusion Devices Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Structural Heart Occlusion Devices Sales and Revenue by Type (2020-2031)

9.4 Central and South America Structural Heart Occlusion Devices Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Structural Heart Occlusion Devices Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Structural Heart Occlusion Devices Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Structural Heart Occlusion Devices Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Structural Heart Occlusion Devices Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Abbott

11.1.1 Abbott Corporation Information

11.1.2 Abbott Business Overview

11.1.3 Abbott Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.1.4 Abbott Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Abbott Structural Heart Occlusion Devices Sales by Product in 2024

11.1.6 Abbott Structural Heart Occlusion Devices Sales by Application in 2024

11.1.7 Abbott Structural Heart Occlusion Devices Sales by Geographic Area in 2024

11.1.8 Abbott Structural Heart Occlusion Devices SWOT Analysis

11.1.9 Abbott Recent Developments

11.2 Medtronic

11.2.1 Medtronic Corporation Information

11.2.2 Medtronic Business Overview

11.2.3 Medtronic Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.2.4 Medtronic Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Medtronic Structural Heart Occlusion Devices Sales by Product in 2024

11.2.6 Medtronic Structural Heart Occlusion Devices Sales by Application in 2024

11.2.7 Medtronic Structural Heart Occlusion Devices Sales by Geographic Area in 2024

11.2.8 Medtronic Structural Heart Occlusion Devices SWOT Analysis

11.2.9 Medtronic Recent Developments

11.3 Boston Scientific

11.3.1 Boston Scientific Corporation Information

11.3.2 Boston Scientific Business Overview

11.3.3 Boston Scientific Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.3.4 Boston Scientific Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Boston Scientific Structural Heart Occlusion Devices Sales by Product in 2024

11.3.6 Boston Scientific Structural Heart Occlusion Devices Sales by Application in 2024

11.3.7 Boston Scientific Structural Heart Occlusion Devices Sales by Geographic Area in 2024

11.3.8 Boston Scientific Structural Heart Occlusion Devices SWOT Analysis

11.3.9 Boston Scientific Recent Developments

11.4 MicroPort

11.4.1 MicroPort Corporation Information

11.4.2 MicroPort Business Overview

11.4.3 MicroPort Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.4.4 MicroPort Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 MicroPort Structural Heart Occlusion Devices Sales by Product in 2024

11.4.6 MicroPort Structural Heart Occlusion Devices Sales by Application in 2024

11.4.7 MicroPort Structural Heart Occlusion Devices Sales by Geographic Area in 2024

11.4.8 MicroPort Structural Heart Occlusion Devices SWOT Analysis

11.4.9 MicroPort Recent Developments

11.5 Shenzhen Salubris Pharmaceuticals

11.5.1 Shenzhen Salubris Pharmaceuticals Corporation Information

11.5.2 Shenzhen Salubris Pharmaceuticals Business Overview

11.5.3 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.5.4 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales by Product in 2024

11.5.6 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales by Application in 2024

11.5.7 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales by Geographic Area in 2024

11.5.8 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices SWOT Analysis

11.5.9 Shenzhen Salubris Pharmaceuticals Recent Developments

11.6 LifeTech

11.6.1 LifeTech Corporation Information

11.6.2 LifeTech Business Overview

11.6.3 LifeTech Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.6.4 LifeTech Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 LifeTech Recent Developments

11.7 Lepu Scientech Medical

11.7.1 Lepu Scientech Medical Corporation Information

11.7.2 Lepu Scientech Medical Business Overview

11.7.3 Lepu Scientech Medical Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.7.4 Lepu Scientech Medical Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Lepu Scientech Medical Recent Developments

11.8 Beijing Balance Medical

11.8.1 Beijing Balance Medical Corporation Information

11.8.2 Beijing Balance Medical Business Overview

11.8.3 Beijing Balance Medical Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.8.4 Beijing Balance Medical Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Beijing Balance Medical Recent Developments

11.9 Bluesail Medical

11.9.1 Bluesail Medical Corporation Information

11.9.2 Bluesail Medical Business Overview

11.9.3 Bluesail Medical Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.9.4 Bluesail Medical Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Bluesail Medical Recent Developments

11.10 Shanghai HeartCare Medical

11.10.1 Shanghai HeartCare Medical Corporation Information

11.10.2 Shanghai HeartCare Medical Business Overview

11.10.3 Shanghai HeartCare Medical Structural Heart Occlusion Devices Product Models, Descriptions and Specifications

11.10.4 Shanghai HeartCare Medical Structural Heart Occlusion Devices Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Shanghai HeartCare Medical Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Structural Heart Occlusion Devices Industry Chain

12.2 Structural Heart Occlusion Devices Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Structural Heart Occlusion Devices Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Structural Heart Occlusion Devices Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Structural Heart Occlusion Devices Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Structural Heart Occlusion Devices Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Shenzhen Salubris Pharmaceuticals

LifeTech

LEPU SCIENTECH MEDICAL

Beijing Balance Medical

Bluesail Medical

Shanghai HeartCare Medical

List of Tables

Table 1. Global Structural Heart Occlusion Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Structural Heart Occlusion Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Structural Heart Occlusion Devices Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Structural Heart Occlusion Devices Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Structural Heart Occlusion Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Structural Heart Occlusion Devices Sales by Region (2020-2025) & (K Units)

Table 8. Global Structural Heart Occlusion Devices Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Structural Heart Occlusion Devices Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Structural Heart Occlusion Devices Sales Share by Manufacturers (2020-2025)

Table 12. Global Structural Heart Occlusion Devices Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Structural Heart Occlusion Devices Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Structural Heart Occlusion Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Structural Heart Occlusion Devices as of 2024)

Table 16. Global Structural Heart Occlusion Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Structural Heart Occlusion Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Structural Heart Occlusion Devices Manufacturing Base and Headquarters

Table 19. Global Structural Heart Occlusion Devices Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Structural Heart Occlusion Devices Sales by Type (2020-2025) & (K Units)

Table 23. Global Structural Heart Occlusion Devices Sales by Type (2026-2031) & (K Units)

Table 24. Global Structural Heart Occlusion Devices Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Structural Heart Occlusion Devices Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Structural Heart Occlusion Devices ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Structural Heart Occlusion Devices Sales by Application (2020-2025) & (K Units)

Table 29. Global Structural Heart Occlusion Devices Sales by Application (2026-2031) & (K Units)

Table 30. Structural Heart Occlusion Devices High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Structural Heart Occlusion Devices Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Structural Heart Occlusion Devices Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Structural Heart Occlusion Devices ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Structural Heart Occlusion Devices Growth Accelerators and Market Barriers

Table 37. North America Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Structural Heart Occlusion Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Structural Heart Occlusion Devices Growth Accelerators and Market Barriers

Table 40. Europe Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Structural Heart Occlusion Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Structural Heart Occlusion Devices Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Structural Heart Occlusion Devices Growth Accelerators and Market Barriers

Table 45. Southeast Asia Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Structural Heart Occlusion Devices Investment Opportunities and Key Challenges

Table 47. Central and South America Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Structural Heart Occlusion Devices Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Structural Heart Occlusion Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Abbott Corporation Information

Table 51. Abbott Description and Major Businesses

Table 52. Abbott Product Models, Descriptions and Specifications

Table 53. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Abbott Sales Value Proportion by Product in 2024

Table 55. Abbott Sales Value Proportion by Application in 2024

Table 56. Abbott Sales Value Proportion by Geographic Area in 2024

Table 57. Abbott Structural Heart Occlusion Devices SWOT Analysis

Table 58. Abbott Recent Developments

Table 59. Medtronic Corporation Information

Table 60. Medtronic Description and Major Businesses

Table 61. Medtronic Product Models, Descriptions and Specifications

Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Medtronic Sales Value Proportion by Product in 2024

Table 64. Medtronic Sales Value Proportion by Application in 2024

Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024

Table 66. Medtronic Structural Heart Occlusion Devices SWOT Analysis

Table 67. Medtronic Recent Developments

Table 68. Boston Scientific Corporation Information

Table 69. Boston Scientific Description and Major Businesses

Table 70. Boston Scientific Product Models, Descriptions and Specifications

Table 71. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Boston Scientific Sales Value Proportion by Product in 2024

Table 73. Boston Scientific Sales Value Proportion by Application in 2024

Table 74. Boston Scientific Sales Value Proportion by Geographic Area in 2024

Table 75. Boston Scientific Structural Heart Occlusion Devices SWOT Analysis

Table 76. Boston Scientific Recent Developments

Table 77. MicroPort Corporation Information

Table 78. MicroPort Description and Major Businesses

Table 79. MicroPort Product Models, Descriptions and Specifications

Table 80. MicroPort Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. MicroPort Sales Value Proportion by Product in 2024

Table 82. MicroPort Sales Value Proportion by Application in 2024

Table 83. MicroPort Sales Value Proportion by Geographic Area in 2024

Table 84. MicroPort Structural Heart Occlusion Devices SWOT Analysis

Table 85. MicroPort Recent Developments

Table 86. Shenzhen Salubris Pharmaceuticals Corporation Information

Table 87. Shenzhen Salubris Pharmaceuticals Description and Major Businesses

Table 88. Shenzhen Salubris Pharmaceuticals Product Models, Descriptions and Specifications

Table 89. Shenzhen Salubris Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Shenzhen Salubris Pharmaceuticals Sales Value Proportion by Product in 2024

Table 91. Shenzhen Salubris Pharmaceuticals Sales Value Proportion by Application in 2024

Table 92. Shenzhen Salubris Pharmaceuticals Sales Value Proportion by Geographic Area in 2024

Table 93. Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices SWOT Analysis

Table 94. Shenzhen Salubris Pharmaceuticals Recent Developments

Table 95. LifeTech Corporation Information

Table 96. LifeTech Description and Major Businesses

Table 97. LifeTech Product Models, Descriptions and Specifications

Table 98. LifeTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. LifeTech Recent Developments

Table 100. Lepu Scientech Medical Corporation Information

Table 101. Lepu Scientech Medical Description and Major Businesses

Table 102. Lepu Scientech Medical Product Models, Descriptions and Specifications

Table 103. Lepu Scientech Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Lepu Scientech Medical Recent Developments

Table 105. Beijing Balance Medical Corporation Information

Table 106. Beijing Balance Medical Description and Major Businesses

Table 107. Beijing Balance Medical Product Models, Descriptions and Specifications

Table 108. Beijing Balance Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Beijing Balance Medical Recent Developments

Table 110. Bluesail Medical Corporation Information

Table 111. Bluesail Medical Description and Major Businesses

Table 112. Bluesail Medical Product Models, Descriptions and Specifications

Table 113. Bluesail Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Bluesail Medical Recent Developments

Table 115. Shanghai HeartCare Medical Corporation Information

Table 116. Shanghai HeartCare Medical Description and Major Businesses

Table 117. Shanghai HeartCare Medical Product Models, Descriptions and Specifications

Table 118. Shanghai HeartCare Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Shanghai HeartCare Medical Recent Developments

Table 120. Key Raw Materials Distribution

Table 121. Raw Materials Key Suppliers

Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 123. Milestones in Production Technology Evolution

Table 124. Distributors List

Table 125. Market Trends and Market Evolution

Table 126. Market Drivers and Opportunities

Table 127. Market Challenges, Risks, and Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Structural Heart Occlusion Devices Product Picture

Figure 2. Global Structural Heart Occlusion Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Patent Ductus Arteriosis (PDA) Occluder Product Picture

Figure 4. Atrial Septal Defects (ASD) Occluder Product Picture

Figure 5. Ventricular Septal Defects (VSD) Occluder Product Picture

Figure 6. Left Atrial Appendage （LAA） Occluder Product Picture

Figure 7. Patent Foramen Ovale (PFO) Occluder Product Picture

Figure 8. Global Structural Heart Occlusion Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Congenital Heart Disease

Figure 10. Cardioembolic Stroke

Figure 11. Structural Heart Occlusion Devices Report Years Considered

Figure 12. Global Structural Heart Occlusion Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 14. Global Structural Heart Occlusion Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Structural Heart Occlusion Devices Revenue Market Share by Region (2020-2031)

Figure 16. Global Structural Heart Occlusion Devices Sales (2020-2031) & (K Units)

Figure 17. Global Structural Heart Occlusion Devices Sales (CAGR) by Region (2020-2031) (K Units)

Figure 18. Global Structural Heart Occlusion Devices Sales Market Share by Region (2020-2031)

Figure 19. Top 5 and Top 10 Manufacturers Structural Heart Occlusion Devices Sales Volume Market Share in 2024

Figure 20. Global Structural Heart Occlusion Devices Revenue Market Share Ranking (2024)

Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 22. Patent Ductus Arteriosis (PDA) Occluder Revenue Market Share by Manufacturer in 2024

Figure 23. Atrial Septal Defects (ASD) Occluder Revenue Market Share by Manufacturer in 2024

Figure 24. Ventricular Septal Defects (VSD) Occluder Revenue Market Share by Manufacturer in 2024

Figure 25. Left Atrial Appendage （LAA） Occluder Revenue Market Share by Manufacturer in 2024

Figure 26. Patent Foramen Ovale (PFO) Occluder Revenue Market Share by Manufacturer in 2024

Figure 27. Global Structural Heart Occlusion Devices Sales Market Share by Type (2020-2031)

Figure 28. Global Structural Heart Occlusion Devices Revenue Market Share by Type (2020-2031)

Figure 29. Global Structural Heart Occlusion Devices Sales Market Share by Application (2020-2031)

Figure 30. Global Structural Heart Occlusion Devices Revenue Market Share by Application (2020-2031)

Figure 31. North America Structural Heart Occlusion Devices Sales YoY (2020-2031) & (K Units)

Figure 32. North America Structural Heart Occlusion Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 33. North America Top 5 Manufacturers Structural Heart Occlusion Devices Sales Revenue (US$ Million) in 2024

Figure 34. North America Structural Heart Occlusion Devices Sales Volume (K Units) by Type (2020- 2031)

Figure 35. North America Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 36. North America Structural Heart Occlusion Devices Sales Volume (K Units) by Application (2020-2031)

Figure 37. North America Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 38. US Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 39. Canada Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 40. Mexico Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 41. Europe Structural Heart Occlusion Devices Sales YoY (2020-2031) & (K Units)

Figure 42. Europe Structural Heart Occlusion Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 43. Europe Top 5 Manufacturers Structural Heart Occlusion Devices Sales Revenue (US$ Million) in 2024

Figure 44. Europe Structural Heart Occlusion Devices Sales Volume (K Units) by Type (2020-2031)

Figure 45. Europe Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Type (2020-2031)

Figure 46. Europe Structural Heart Occlusion Devices Sales Volume (K Units) by Application (2020-2031)

Figure 47. Europe Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 48. Germany Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 49. France Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 50. U.K. Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 51. Italy Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 52. Russia Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 53. Asia-Pacific Structural Heart Occlusion Devices Sales YoY (2020-2031) & (K Units)

Figure 54. Asia-Pacific Structural Heart Occlusion Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Asia-Pacific Top 8 Manufacturers Structural Heart Occlusion Devices Sales Revenue (US$ Million) in 2024

Figure 56. Asia-Pacific Structural Heart Occlusion Devices Sales Volume (K Units) by Type (2020- 2031)

Figure 57. Asia-Pacific Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 58. Asia-Pacific Structural Heart Occlusion Devices Sales Volume (K Units) by Application (2020-2031)

Figure 59. Asia-Pacific Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 60. Indonesia Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 61. Japan Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 62. South Korea Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 63. China Taiwan Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 64. India Structural Heart Occlusion Devices Revenue (2020-2031) & (US$ Million)

Figure 65. Central and South America Structural Heart Occlusion Devices Sales YoY (2020-2031) & (K Units)

Figure 66. Central and South America Structural Heart Occlusion Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 67. Central and South America Top 5 Manufacturers Structural Heart Occlusion Devices Sales Revenue (US$ Million) in 2024

Figure 68. Central and South America Structural Heart Occlusion Devices Sales Volume (K Units) by Type (2021-2031)

Figure 69. Central and South America Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Type (2020-2031)

Figure 70. Central and South America Structural Heart Occlusion Devices Sales Volume (K Units) by Application (2020-2031)

Figure 71. Central and South America Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 72. Brazil Structural Heart Occlusion Devices Revenue (2020-2025) & (US$ Million)

Figure 73. Argentina Structural Heart Occlusion Devices Revenue (2020-2025) & (US$ Million)

Figure 74. Middle East, and Africa Structural Heart Occlusion Devices Sales YoY (2020-2031) & (K Units)

Figure 75. Middle East and Africa Structural Heart Occlusion Devices Revenue YoY (2020-2031) & (US$ Million)

Figure 76. Middle East and Africa Top 5 Manufacturers Structural Heart Occlusion Devices Sales Revenue (US$ Million) in 2024

Figure 77. Middle East and Africa Structural Heart Occlusion Devices Sales Volume (K Units) by Type (2021-2031)

Figure 78. South America Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Type (2020-2031)

Figure 79. Middle East and Africa Structural Heart Occlusion Devices Sales Volume (K Units) by Application (2020-2031)

Figure 80. Middle East and Africa Structural Heart Occlusion Devices Sales Revenue (US$ Million) by Application (2020-2031)

Figure 81. GCC Countries Structural Heart Occlusion Devices Revenue (2020-2025) & (US$ Million)

Figure 82. Turkey Structural Heart Occlusion Devices Revenue (2020-2025) & (US$ Million)

Figure 83. Egypt Structural Heart Occlusion Devices Revenue (2020-2025) & (US$ Million)

Figure 84. South Africa Structural Heart Occlusion Devices Revenue (2020-2025) & (US$ Million)

Figure 85. Structural Heart Occlusion Devices Industry Chain Mapping

Figure 86. Regional Structural Heart Occlusion Devices Manufacturing Base Distribution (%)

Figure 87. Global Structural Heart Occlusion Devices Production Market Share by Region (2020-2031)

Figure 88. Structural Heart Occlusion Devices Production Process

Figure 89. Regional Structural Heart Occlusion Devices Production Cost Structure

Figure 90. Channels of Distribution (Direct Vs Distribution)

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions